Publications by Maryam Zanjirband Zanjirband - ePrints

Newcastle Authors	Title	Year
Maryam Zanjirband Zanjirband Professor Nicola Curtin Professor John Lunec	Erratum: Correction: Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer (Oncotarget (2017) 8 41 (69779-69796))	2024
Lucy Gentles Liz Matheson Dr Nicholas Bown Alice Bradbury Maryam Zanjirband Zanjirband et al.	Characterization and drug sensitivity of a novel human overian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor	2018
Maryam Zanjirband Zanjirband Professor Nicola Curtin Professor John Lunec	Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer	2017
Maryam Zanjirband Zanjirband Professor Richard Edmondson Professor John Lunec	Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents in combined treatment with cisplatin in ovarian cancer	2016